Burns McClellan
Advertising Networks · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
853 Bdy Ste 2014, New York City, New Yor...Website
www.burnsmcclellan.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Burns McClellan
Burns McClellan specializes in providing integrated communications services exclusively for the life sciences industry. Established in 1988, the company offers a range of services including investor relations, public relations, and advisory services tailored to meet the needs of both private and public life sciences organizations. They focus on creating compelling narratives and delivering outstanding service to help clients navigate capital raising and corporate communications. With a strong network of investors, analysts, and media, Burns McClellan supports companies at all stages of development, from seed funding to product commercialization.Explore more
Burns McClellan Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Burns McClellan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Burns McClellan
Click to see if Burns McClellan had a recent Job posting/layoffs
Check if Burns McClellan has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Burns McClellan launches new products
Earning: See what the market has to say on Burns McClellan recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Burns McClellan, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Burns McClellan is spiking on competitors!
Funding: Get notified immidiatlly once Burns McClellan has new funding data
Recommended Actions
Find VP level buyers at Burns McClellan
Find 3 more new buyers
Compare Similar Companies to Burns McClellan
Compare insights from companies similar to Burns McClellan, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Burns McClellan is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Burns McClellan is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Burns McClellan.
Burns McClellan financials insights
Gather financial insights about Burns McClellan, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Burns McClellan Tech Stack
A closer look at the technologies used by Burns McClellan
See more technologies
Most Recent Scoops
Promotion
Executive Move
Burns McClellan has announced that Diana Boter has been promoted from Executive VP & Head of Investor Relations to the role of President.
Executive Moves, Promotion
Executive Move
Lisa Burns, Chief Executive Officer, has passed away.
Executive Moves
Promotion
Executive Move
Burns McClellan has announced that Diana Boter has been promoted from Chief Financial & Operating Officer to the role of Chief Executive Officer.
Executive Moves, Promotion
Funding
Burns McClellan News & Media
Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement in Progressive Multiple Sclerosis Patients Treated with ATA190, an Autologous Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy
Findings reported in an article online and to be published in the December 2018 issue of the JCI Insight Findings reported in an article online and to be published in the December 2018 issue of the JCI InsightArix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound
LONDON, November 15, 2018 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical research company focused on inflammation and...Ovid Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that the company will present at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2018 at 11:00 a.m. EST. The conference will be held at the Lotte New York Palace. A live audio webcast of the presentation can be accessed throughOvid Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that the company will present at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2018 at 11:00 a.m. EST. The conference will be held at the Lotte New York Palace. A live audio webcast of the presentation can be accessed through
Read more news
Top Advertising Networks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Burns McClellan
Sign Up For FreeTo access detailed company insights
Burns McClellan specializes in providing integrated communications services exclusively for the life sciences industry. Established in 1988, the company offers a range of services including investor relations, public relations, and advisory services tailored to meet the needs of both private and public life sciences organizations. They focus on cre... Read More
